Large Scale Biology Q3 Revenues Plummet 58 Percent As 2003 Closure of Contract Proteomics Unit Takes Toll | GenomeWeb

NEW YORK , Nov. 4 (GenomeWeb News) - Large Scale Biology, owner of Predictive Diagnostics, today said that third-quarter revenue nosedived 58 percent, to $500,000 from $1.2 million one year ago.

The Vacaville, Calif.-based company did not break out figures for its wholly owned biomarker-company subsidiary.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.